Drug-Resistant Tuberculosis in High-Risk Groups, Zimbabwe

Drug-Resistant Tuberculosis in High-Risk Groups, Zimbabwe

To estimate prevalence of multidrug-resistant tuberculosis (MDR TB) in Harare, Zimbabwe, in 2012, we performed microbiologic testing on acid-fast bacilli smear-positive sputum samples from patients previously treated for TB. Twenty (24%) of 84 specimens were consistent with MDR TB. A national drug-r...

Full description

Bibliographic Details
Main Authors: John Z. Metcalfe, Salome Makumbirofa, Beauty Makamure, Charles Sandy, Wilbert Bara, Stanley Mungofa, Philip C. Hopewell, Peter Mason
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2014-01-01
Series:Emerging Infectious Diseases
Subjects:
drug-resistant tuberculosis
HIV/TB
retreatment tuberculosis
Zimbabwe
mycobacteria
tuberculosis
Online Access:https://wwwnc.cdc.gov/eid/article/20/1/13-0732_article
Description
Summary:To estimate prevalence of multidrug-resistant tuberculosis (MDR TB) in Harare, Zimbabwe, in 2012, we performed microbiologic testing on acid-fast bacilli smear-positive sputum samples from patients previously treated for TB. Twenty (24%) of 84 specimens were consistent with MDR TB. A national drug-resistance survey is needed to determine MDR TB prevalence in Zimbabwe.
ISSN:1080-6040
1080-6059

Similar Items